HomeAbout

TL;DR CNBC


Moderna strikes deal to develop mRNA drugs in China - TL;DR CNBC

Moderna strikes deal to develop mRNA drugs in China

Publishing timestamp: 2023-07-05 09:19:31


Summary

Moderna has struck a deal with Chinese officials to research, develop, and manufacture messenger RNA medicines exclusively for the Chinese population. This deal comes despite rising tensions between the U.S. and China. Moderna is capitalizing on the success of its Covid vaccine, which uses mRNA technology. This is Moderna's first agreement with China and expands beyond Covid shots to include the development of mRNA medicines overall. The deal comes at a time when tensions between the U.S. and China are high, and the Biden administration is taking measures to diversify away from China in investment and trade.


Sentiment: NEUTRAL

Tickers: SAN-FRNOVO.B-DKPFEAZN-GBMRNAMRKGEHC

Keywords: health care industrybiotechnologysanofi sabusiness newspharmaceuticalsmerck & co incnovo nordisk a/sforeign policyge healthcare technologies incchinapfizer incbiotech and pharmaceuticalsmoderna incastrazeneca plcbusiness

Source: https://www.cnbc.com/2023/07/05/moderna-strikes-deal-to-develop-mrna-drugs-in-china-.html


Developed by Leo Phan